Efficacy of a Smart Antisnore Pillow in Patients with Obstructive Sleep Apnea Syndrome

Objective. Untreated obstructive sleep apnea syndrome (OSAS) increases the risk of cardiovascular, dementia, and motor vehicle accident events. However, continuous positive airway pressure (CPAP) which is the gold standard treatment is not acceptable for many patients with OSAS. Development of devic...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural neurology 2021, Vol.2021, p.8824011-6
Main Authors: Chung, Tsung-Te, Lee, Ming-Tsung, Ku, Ming-Chou, Yang, Kai-Chieh, Wei, Cheng-Yu
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Body mass index
Care and treatment
Continuous Positive Airway Pressure
Female
Hospitals
Humans
Male
Middle Aged
Oxygen saturation
Pilot Projects
Polysomnography
Prospective Studies
Questionnaires
Sensors
Sleep apnea
Sleep apnea syndromes
Sleep Apnea, Obstructive - therapy
Sleep deprivation
Sound
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. Untreated obstructive sleep apnea syndrome (OSAS) increases the risk of cardiovascular, dementia, and motor vehicle accident events. However, continuous positive airway pressure (CPAP) which is the gold standard treatment is not acceptable for many patients with OSAS. Development of devices for the patients of nonadherence to CPAP is necessary. Materials and Methods. We evaluated the effect of the smart antisnore pillow (SAP) in patients with OSAS in a prospective, noncontrolled, nonrandomized, pilot study. According to the apnea-hypopnea index (AHI), they were divided into two groups: mild-to-moderate OSAS group and severe OSAS group. Single-night polysomnography (PSG) with application of a SAP was performed. Thirty patients, 15 males and 15 females, 33–82 years old (mean age, 59.3±12.9 years), completed the smart antisnore pillow therapy test. Among them, 23 patients had mild-to-moderate OSAS. Results. The SAP significantly improved the snore number (p=0.018), snore index (p=0.013), oxygen denaturation index (p=0.001), total AHI (p=0.002), and supine AHI (p=0.002) in the mild-to-moderate OSAS group, but there was no significant improvement in the severe OSAS group. Conclusions. We concluded that the SAP is an effective positional therapy device for patients with OSAS of mild-to-moderate severity.
ISSN:0953-4180
1875-8584
DOI:10.1155/2021/8824011